AVTR vs WAT
AVTR: A global provider of mission-critical products and services for laboratory research and production workflows across biopharma and advanced industries. WAT: Waters Corporation provides high-performance liquid chromatography and mass spectrometry systems that are essential for analytical testing in the pharmaceutical and life sciences industries.
Side-by-side fundamentals
| Metric | AVTR | WAT | Edge |
|---|---|---|---|
| Price as of 2026-10-08 close | $15.39 | $429.13 | |
| Market cap | $10.5B | $42.2B | |
| P/E as of 2026-10-08 | n/a | 107.31 | |
| Net margin FY2025, SEC XBRL | -8.1% | +20.3% | WAT higher |
| Gross margin FY2025, SEC XBRL | +32.7% | n/a | |
| Operating margin FY2025, SEC XBRL | -3.8% | +25.4% | WAT higher |
| ROE FY2025, SEC XBRL | -9.5% | +25.1% | WAT higher |
| ROA FY2025, SEC XBRL | -4.5% | +12.7% | WAT higher |
| Debt / equity as of 2026-09-03 | 0.66 | 0.33 | WAT lower |
| Revenue growth (YoY) as of 2026-09-03 | -1.6% | n/a | |
| Revenue CAGR (3y) SEC XBRL | -4.5% | +2.1% | WAT higher |
| Dividend streak (yrs) SEC XBRL | 0 | 0 | Tie |
| Beta as of 2026-09-03 | 0.98 | 0.96 | |
| 1-year return as of 2026-10-08 close | +11.9% | +31.0% | WAT higher |
Fundamentals: SEC XBRL company filings for the figures marked with a fiscal year, and market data, as of 2026-09-03 for the rest. Filings: SEC EDGAR. Prices are delayed daily-close data.
Last updated 2026-10-08.
Informational only — NOT financial advice. All figures are delayed daily-close data from SEC EDGAR & market data, shown with their as-of date; "Edge" cells are a pure numeric comparison, not a recommendation.